Amsterdam’s Phillips to Pay $62M to U.S. for China Sales Misconduct
The U.S. Securities and Exchange Commission reported that Amsterdam-based health technology firm Koninklijke Philips N.V. will pay more than $62 million to resolve charges that it violated the Foreign Corrupt Practices Act (FCPA) with respect to its sales of medical …
